Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 100.
376. lappuse
... drying period . Dry at a temperature of 60 ° C. and a pressure of 5 millimeters of mercury or less for 3 hours . At the end of the dry- ing period , fill the vacuum oven with air dried by passing it through a drying agent such as ...
... drying period . Dry at a temperature of 60 ° C. and a pressure of 5 millimeters of mercury or less for 3 hours . At the end of the dry- ing period , fill the vacuum oven with air dried by passing it through a drying agent such as ...
520. lappuse
... drying is not more than 1.5 percent . ( iii ) The pH of an aqueous solution containing 60 milligrams per milliliter ... drying , pH , penicillin G content , and crystrallinity . ( ii ) Samples , if required by the Cen- ter for Drug ...
... drying is not more than 1.5 percent . ( iii ) The pH of an aqueous solution containing 60 milligrams per milliliter ... drying , pH , penicillin G content , and crystrallinity . ( ii ) Samples , if required by the Cen- ter for Drug ...
521. lappuse
... drying is not more than 1.5 percent . ( vi ) Its pH in an aqueous solution containing 60 milligrams per milliliter is not less than 5.0 and not more than 7.5 . ( vii ) Its penicillin G content is not less than 80.8 percent and not more ...
... drying is not more than 1.5 percent . ( vi ) Its pH in an aqueous solution containing 60 milligrams per milliliter is not less than 5.0 and not more than 7.5 . ( vii ) Its penicillin G content is not less than 80.8 percent and not more ...
522. lappuse
... drying is not more than 1.5 percent . ( vi ) Its pH in an aqueous solution containing 60 milligrams per milliliter is not less than 5.0 and not more than 7.5 . ( vii ) Its penicillin G content is not less than 84.5 percent and not more ...
... drying is not more than 1.5 percent . ( vi ) Its pH in an aqueous solution containing 60 milligrams per milliliter is not less than 5.0 and not more than 7.5 . ( vii ) Its penicillin G content is not less than 84.5 percent and not more ...
533. lappuse
... drying , pH , ampicillin content , concordance , crystallinity , and identity . ( b ) The batch for potency , loss on drying , and disintegration time . ( ii ) Samples required : ( a ) The ampicillin used in making the batch : 10 ...
... drying , pH , ampicillin content , concordance , crystallinity , and identity . ( b ) The batch for potency , loss on drying , and disintegration time . ( ii ) Samples required : ( a ) The ampicillin used in making the batch : 10 ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning